本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

武田製藥

14.43
-0.3100-2.10%
盤後14.430.00000.00%16:53 EDT
成交量:364.40萬
成交額:5,289.97萬
市值:455.73億
市盈率:64.28
高:14.72
開:14.72
低:14.41
收:14.74
資料載入中...
2022/01/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/14

超過5%披露

TAKEDA PHARMACEUTICAL CO LTD
2021/09/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/29

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]